vweasc
13th -
14th
August 2024 | 
Songdo Convention Center , South Korea

Advancing Business, Technology and Innovation for Vaccines in East Asia

13th -
14th
August 2024 | 
Songdo Convention Center , South Korea
📆 Add to Google Calendar
0 +
Attendees
0 +
Companies
0 +
Speakers
0 +
In-Person Networking Hours
0 +
Co-located Event - BMK 2024

Concept

In the face of dynamic global health challenges, the imperative for ground breaking solutions has surged to unprecedented heights. The 6th Vaccine World East Asia Congress emerges as a pivotal rendezvous point, uniting brilliant minds to explore and deliberate on cutting-edge advancements in vaccine research and development (R&D), innovative manufacturing processes, and the transformative potential of state-of-the-art technologies.

Our agenda is poised to nurture collaboration, facilitate the exchange of insights, and showcase ground breaking case studies that illuminate the path ahead in vaccine development and manufacturing. From delving into the frontiers of immunology breakthroughs to dissecting the intricacies of precision manufacturing, the 6th Vaccine World East Asia Congress is committed to navigating the ever-evolving terrain of vaccine innovation.

Key themes in the discussions include the swift acceleration of research initiatives, the optimization of manufacturing capabilities, and the seamless integration of novel technologies poised to revolutionize vaccine development. With an extraordinary assembly of visionaries, innovators, and leaders propelling the forefront of vaccine research and development, delegates can eagerly anticipate engaging in thought-provoking discussions that traverse the latest trends, navigate challenges, and celebrate success stories shaping the future of vaccines not only in East Asia but on a global scale.

Vaccine World East Asia 2024

East Asia Vaccine R&D, Manufacturing & Supply Chain Challenges & Opportunities: Industry leaders convene to discuss the challenges and opportunities in vaccine research, manufacturing, and supply chain management across East Asia, addressing topics such as technology innovation, regulatory hurdles, and regional collaboration.

Discusses innovative strategies and methodologies in vaccine clinical trials and research and development, including adaptive trial designs, novel adjuvants, and antigen discovery platforms to expedite vaccine development.

Discusses innovative approaches and technologies in designing next-generation vaccines, including novel delivery systems, antigen design, and immunomodulatory strategies to enhance efficacy and safety.

Presents case studies and success stories of vaccine research and manufacturing initiatives in East Asia, highlighting technological innovations, collaboration models, and market dynamics.

Focuses on the upstream and downstream processes involved in vaccine manufacturing, covering topics such as cell culture techniques, purification methods, and optimization strategies to enhance production yield and quality.

Focuses on the critical aspects of aseptic fill-finish operations and packaging in vaccine manufacturing, addressing technologies, equipment, and regulatory considerations to ensure product sterility and integrity.

Examines challenges and solutions in managing the vaccine supply chain, with a focus on temperature-sensitive products, discussing logistics strategies, cold chain management, and risk mitigation measures.

Explores the current state and future prospects of mRNA vaccines, including technological advancements, clinical applications, and potential breakthroughs in vaccine development and delivery.

THANK YOU TO OUR SPONSORS









Vaccine World East Asia 2024

2023 Past Speakers

MicrosoftTeams-image (23)

Ameet Ambarkhane

Head of Technical Developent, ACM Biolabs, Singapore

Aprilia-Paramitasari_photo_profile

Aprilia Paramitasari

Medical Doctor, Taipei Medical University, Taiwan

Arina-Privalova_photo_profile

Arina Privalova

Strategic Development Director

Nanolek
Russia
Arindam-Ray_photo_profile

Arindam Ray

India Country Lead Immunisation & Surveillance

Bill & Melinda Gates Foundation
India
Chandi-Prasad-Ravipati_photo_profile

Chandi Prasad Ravipati

Head - Packaging Development

Aurobindo Pharma
India
Christina-Henderson

Christina Henderson

Project Manager

The University of Queensland
Australia
david

David Wang

Senior Data Scientist

Sartorius
Singapore
MicrosoftTeams-image (24)

Navneet Biccha

Scientist, WHO-TDR Scholar

IIHMR
India
Nikolai-Petroversky_photo_profile

Nikolai Petroversky

Chairman and  Research Director, Vaxine Pty Ltd, Australia  and Professor of Medicine at Flinders University

Ravi-Ganapathy_photo_profile

Ravi Ganapathy

Director, CMC R&D, Hilleman Laboratory, Singapore

Rhiannon-Dalrymple

Rhiannon Dalrymple

Project Manager

The University of Queensland
Australia
MicrosoftTeams-image (12)

Sherlock Lai

Medical Director

Moderna
Singapore
Sunil-Gadekar_photo_profile

Sunil Gadekar

Global Director- Advanced Therapies, Manufacturing Science and Technology

Johnson & Johnson
Singapore
Sunjong-Kwon_photo_profile-3

Sunjong Kwon

Executive Director, EyeGene, South Korea

Sushant-Sahastrabuddhe_photo_profile

Sushant Sahastrabuddhe

Associate Director General, International Vaccines Institute, S.Korea

Susu-Zughaier_photo_profile

Susu Zughaier

Associate Professor of Microbiology and Immunology, College of Medicine, Qatar University, Qatar

Tim-Collard_photo_profile

Tim Collard

Chief Executive Officer, Pacific GeneTech, Hong Kong

Wonil-Kim

Wonil Kim

Director of R&D Center

GeneOne Life Science
South Korea
Wu-Ke

Wu Ke

Founder and CEO

BravoBio and BravoVax
China

DELEGATE REGISTRATION

Catch the limited super access in time to save BIG!

BIOPHARMA BASED IN KOREA
Limited Super SGD 1459/- (Ends by 3rd March 2023)
  • Limited Special SGD 1695/- (Ends by 28th April 2023)
  • Early Bird SGD 1895/- (Ends by 2nd June 2023)
  • Standard Rate SGD 2095/- (Ends by 3rd March 2023)
ASIAN AND INTERNATIONAL BIOPHARMA
Limited Super SGD 2395/- (Ends by 3rd March 2023)
  • Limited Special SGD 2595/- (Ends by 28th April 2023)
  • Early Bird SGD 2895/- (Ends by 2nd June 2023)
  • Standard Rate SGD 3195/- (Ends by 3rd March 2023)
SOLUTION PROVIDERS
Limited Super SGD 4095/- (Ends by 3rd March 2023)
  • Limited Special SGD 4395/- (Ends by 28th April 2023)
  • Early Bird SGD 4695/- (Ends by 2nd June 2023)
  • Standard Rate SGD 4895/- (Ends by 3rd March 2023)

#BUZZ ABOUT THE EVENT

SIMILAR EVENTS

Download Post Event Report Form

Download Attendee List

Download Prospectus Document Form

Download Brochure Document Form

Sponsorship Form

Download Agenda Form

Apply For Speaking Opportunity

Download List of Biopharma, CMO, CRO, CDMO and Big Pharma in China and Taiwan Brochure

Download Strategic Consulting Brochure

Download Case Study Consulting Digital Disruption

Download Case Study Consulting Revolutionizing Biopharmaceuticals

Download IMAPAC Custom Events Prospectus

Download Case Study : Fill-Finish Solution provider increasing its market share

Download Case Study : European CMO expanding into APAC

Download Case Study : China CDMO's New Gene Protein Facility Opening

Download Biologics Newsletter Sample

Download Cell and Gene Therapy Newsletter Sample

Download Vaccines Newsletter Sample

Download 1:1 Networking Meetings Case Study- High-end assembly solutions provider

Download 1:1 Networking Meetings Case Study- IT/Software Solution provider

Download 1:1 Networking Meetings Case Study- Biopharma Courier Service Provider

Download Ebook

Download Ebook

Download Events Calendar

Customised Webinar/Webcast

Download Customised Events Brochure

Contact us for Third Party Email Services

Download Newsletter Press Kit

Download Network Meetings Prospectus

Download Media Kit